돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 552079생성일: 2026년 10월 25일

Dicyclohexylcarbodiimide → HCID 178448382, 화합물

https://huagongshe.com/reaction/552079

반응식

참여 물질

역할이름HCID투입량
반응물DicyclohexylcarbodiimideHCID 10868—
반응물Boc-L-ValineHCID 83693—
반응물DCC Boc-ValHCID 131727499—
반응물HCID 178508933HCID 178508933—
용매DimethylformamideHCID 6228—
생성물HCID 178448382HCID 178448382—

반응 단계

A mixture of the desired stereoisomeric form of Boc-Val, and dicyclohexyl carbodiimide (DCC), in dimethylformamide (DMF) in a ratio of 1:2 DCC/Boc-Val was stirred for 1 hr at 0° C. under nitrogen atmosphere. A solution of acyclovir (1) and 4-N,N(dimethylamino) pyridine (DMAP) was added to the reaction mixture, stirred for 18 hrs and then filtered. The solvent of the filtrate was partially removed in vacuo and the impure solution was added dropwise to cold diethyl ether. The resulting precipitate (2) was filtered and dried, followed by acidolytic removal (treating Boc-Val-ACV with trifluoroacetic acid (TFA) for 30 min at 0° C.) of the Boc protecting group to yield Val-ACV (3). Compound (3) was neutralized by triethylamine (TEA) and treated with the amino acid anhydride of Boc-Val for about hrs. The solvent was removed from the reaction mixture in vacuo and the reaction mixture was added dropwise to the cold diethyl ether. The resulting precipitate (4) was filtered, dried and the Boc group was deprotected (acidolytic removal) to yield the desired dipeptide ester of acyclovir Val-Val-ACV (5).

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US07951774B2
출처 데이터셋uspto-grants-2011_05
ORD IDord-1f5703a30f154dbfb206f4675e516fda
출처 메모uspto-grants-2011_05